Coca-Cola proved to be the strongest US brand by posting a Brand Strength Index (BSI) score of 93.3, higher than Google, YouTube, Amazon, and Deloitte, according to a TradingPlatforms.com analysis.
The BSI rating also places Coca-Cola 2.2 points ahead of rival beverage company Pepsi.
The Brand Loyalty and Recommendation Forecast data, which reflects consumer perceptions, preferences, and intentions both online and offline, is the basis for the BSI score ranking.
Additionally, the renowned beverage business has a correspondingly prestigious AAA+ rating.
TradingPlatforms’ financial expert Edith Reads attributed Coca-Cola’s brand strength to the prominence of its core drink in the consumer’s mind, and recent innovations such as new flavors and lower sugar variants.
The BSI score, she continued, is a gauge of consumer loyalty, which can only be attained by having a remarkable level of brand awareness and high consumer approval ratings.
To satisfy consumer demand in a period of growing health consciousness, the company has concentrated on offering low-nutrition and alternative products like Coke Zero.
In a time of disrupted supply chains, it has also strategically chosen to use e-commerce to guarantee brand availability. In addition to its strong product strategy, which helped Coca-Cola ascend to the top, the company's digital strategy has also increased sales.


Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
South Korea Factory Activity Hits 18-Month High as Export Demand Surges
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Japan’s Agricultural, Forestry and Fishery Exports Hit Record High in 2025 Despite Tariffs
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Asian Currencies Strengthen as Indian Rupee and Australian Dollar Rally
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Oil Prices Slide Nearly 3% as U.S.-Iran Talks Ease Geopolitical Tensions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Gold and Asian Stocks Rebound as Market Volatility Eases and Global Sentiment Improves 



